Publication | Closed Access

First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study

HepatologyMedicinePathologyCancer TreatmentOncologyRadiation OncologyHepatocellular CarcinomaFirst-line GemcitabinePreliminary StudyAdvanced Hepatocellular Carcinoma